Estudio para evaluar la seguridad y la eficacia de una combinación de favezelimab y pembrolizumab en participantes con neoplasias malignas hematológicas
This study will evaluate the safety and efficacy of favezelimab (MK-4280) in combination with pembrolizumab (MK-3475) using a non-randomized study design in participants with the following hematological malignancies: classical Hodgkin lymphoma